ORXES Trademark

Trademark Overview


On Friday, June 6, 2025, a trademark application was filed for ORXES with the United States Patent and Trademark Office. The USPTO has given the ORXES trademark a serial number of 99221728. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 2, 2025. This trademark is owned by ORxes Therapeutics Co., Ltd.. The ORXES trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Medicinal preparations for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Pharmaceutical preparations for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Plant extracts, other than essential oils, for pharmaceutical purposes; Diagnostic preparations for medical purposes; Medicated shampoo; Biologics in the nature of pharmaceutical preparations for the treatment of pulmonary arterial hypertension, hypertension, and stroke; Biological preparations for the prevention and treatment of pulmonary arterial hypertension, hypertension, and stroke
orxes

General Information


Serial Number99221728
Word MarkORXES
Filing DateFriday, June 6, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 2, 2025

Trademark Statements


Pseudo MarkORES RX
Goods and ServicesChemical preparations for pharmaceutical or medical purposes, namely, for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Medicinal preparations for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Pharmaceutical preparations for the treatment and prevention of pulmonary arterial hypertension, hypertension, and stroke; Plant extracts, other than essential oils, for pharmaceutical purposes; Diagnostic preparations for medical purposes; Medicated shampoo; Biologics in the nature of pharmaceutical preparations for the treatment of pulmonary arterial hypertension, hypertension, and stroke; Biological preparations for the prevention and treatment of pulmonary arterial hypertension, hypertension, and stroke
Description of MarkThe mark consists of the stylized wording “ORXES” with the letter “X” formed with the tail of the letter “R”.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 6, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameORxes Therapeutics Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type22 - NOT AVAILABLE
AddressShenyang, Liaoning 110136
CN

Party NameORxes Therapeutics Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type22 - NOT AVAILABLE
AddressShenyang, Liaoning 110136
CN

Trademark Events


Event DateEvent Description
Friday, June 6, 2025NEW APPLICATION ENTERED
Friday, June 6, 2025APPLICATION FILING RECEIPT MAILED
Monday, October 13, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 27, 2025ASSIGNED TO EXAMINER
Thursday, October 30, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 2, 2025PUBLISHED FOR OPPOSITION
Tuesday, December 2, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED